3 completed, 1 unknown. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Substance Use Disorder: new trials by email Literature Review of Substance Use Disorder trials Research Report on Substance Use Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EXHIT ENTRE Comparative Effectiveness Trial Extended Release Buprenorphine, Treatment as Usual - Substance Use Disorder, Opioid Use Disorder, Moderate | Phase 2 / Phase 3 | Completed | Gavin Bart | 344 | 2021-08-09 | 2025-12-09 |
| Varenicline Treatment for Cannabis Use Disorder Varenicline, Placebo - Substance Use Disorder | Phase 2 | Completed | Medical University of South Carolina | 72 | 2017-02-13 | 2019-12-03 |
| Cannabidiol and Cocaine Craving/Dependence Cannabidiol - Substance Use Disorder, Cocaine Dependence | Phase 2 | Completed | Centre hospitalier de l'Université de Montréal (CHUM) | 79 | 2016-07-01 | 2020-10-23 |
| Mindfulness and Acceptance Group Therapy for Substance Use Mindfulness + Residential Treatment, Residential treatment alone - Substance Use Disorder | Phase 2 | Unknown | The University of Tennessee, Knoxville | 150 | 2012-08-01 | 2012-12-18 |
Substance-Related Disorders (4) · Cocaine-Related Disorders (1) · Lymphoma, Follicular (1) · Marijuana Use (1) · Opioid-Related Disorders (1)
Chemically-Induced Disorders (4) · Mental Disorders (4) · Behavior (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Narcotic-Related Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Cannabidiol (1) · Dosage Forms (1) · Mindfulness (1) · Residential Treatment (1) · Therapeutics (1) · Varenicline (1)
Centre hospitalier de l'Université de Montréal (CHUM) (1) · Gavin Bart (1) · Medical University of South Carolina (1) · The University of Tennessee, Knoxville (1)
United States (3) · Canada (1)
Aimee McRae-Clark, PharmD (1) · Didier Jutras-Aswad, MD,MS,FRCPC (1) · Gavin Bart, MD,PhD (1)
PMID 33464660, PMID 35135986, PMID 38770686, PMID 39623502
5UG1DA040316-05 (1), UG3DA043231 (1)